glp-1 alcohol reduction medications: The next big thing in use disorder treatment? – Recovery Research Institute GLP-1 Reduced Alcohol Related Hospitalizations

197 Collectively, these pleiotropic effects position GLP-1R agonists as promising therapeutic agents for improving cardiovascular outcomes, extending their benefits far beyond glycemic control

10.1016/j.ccr.2011.01.038 102 JansenR

Recommended Actions: Verify batch numbers through pharmacies

It enhances insulin secretion in response to meals, inhibits glucagon release (which helps prevent the liver from producing too much glucose), and promotes satiety, reducing food intake

No adverse side effects of liraglutide were observed in our patient case

This means that they dont have to meet the same rigorous standards of testing, manufacturing, and quality control as FDA-approved medications